These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


429 related items for PubMed ID: 9334429

  • 41. Polydipsia and dopamine: behavioral effects of dopamine D1 and D2 receptor agonists and antagonists.
    Mittleman G, Rosner AL, Schaub CL.
    J Pharmacol Exp Ther; 1994 Nov; 271(2):638-50. PubMed ID: 7965779
    [Abstract] [Full Text] [Related]

  • 42. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ, Marshall JF.
    Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
    [Abstract] [Full Text] [Related]

  • 43. Dopamine receptor coupling to adenylyl cyclase in rat olfactory pathway: a combined pharmacological-radioautographic approach.
    Coronas V, Krantic S, Jourdan F, Moyse E.
    Neuroscience; 1999 Apr; 90(1):69-78. PubMed ID: 10188934
    [Abstract] [Full Text] [Related]

  • 44. Dopamine D1 and D2 effects on fetal mouthing responses to milk.
    Smotherman WP, Robinson SR.
    Physiol Behav; 1995 Jan; 57(1):15-9. PubMed ID: 7878109
    [Abstract] [Full Text] [Related]

  • 45. Enhancement of excessive lever-pressing after post-training signal attenuation in rats by repeated administration of the D1 antagonist SCH 23390 or the D2 agonist quinpirole, but not the D1 agonist SKF 38393 or the D2 antagonist haloperidol.
    Joel D, Avisar A, Doljansky J.
    Behav Neurosci; 2001 Dec; 115(6):1291-300. PubMed ID: 11770060
    [Abstract] [Full Text] [Related]

  • 46. D1-D2 dopamine receptor synergy in striatum: effects of intrastriatal infusions of dopamine agonists and antagonists on immediate early gene expression.
    Keefe KA, Gerfen CR.
    Neuroscience; 1995 Jun; 66(4):903-13. PubMed ID: 7651617
    [Abstract] [Full Text] [Related]

  • 47. D1 receptors modulate striatal dopamine release induced by the stimulation of both D1 and D2 receptors: in vivo voltammetric data revisited.
    Fechtali T, Issoual D, Abraini JH.
    J Physiol Paris; 1994 Jun; 88(5):331-3. PubMed ID: 7787831
    [Abstract] [Full Text] [Related]

  • 48. Selective dopamine antagonist pretreatment on the antiparkinsonian effects of benzazepine D1 dopamine agonists in rodent and primate models of Parkinson's disease--the differential effects of D1 dopamine antagonists in the primate.
    Gnanalingham KK, Hunter AJ, Jenner P, Marsden CD.
    Psychopharmacology (Berl); 1995 Feb; 117(4):403-12. PubMed ID: 7604140
    [Abstract] [Full Text] [Related]

  • 49. N-methyl-D-aspartate receptor blockade differentially modifies regional cerebral metabolic responses to D1 and D2 dopamine agonists in rats with a unilateral 6-hydroxydopamine lesion.
    Engber TM, Anderson JJ, Boldry RC, Kuo S, Chase TN.
    Neuroscience; 1993 Jun; 54(4):1051-61. PubMed ID: 8101981
    [Abstract] [Full Text] [Related]

  • 50. Do D1/D2 interactions regulate prepulse inhibition in rats?
    Wan FJ, Taaid N, Swerdlow NR.
    Neuropsychopharmacology; 1996 Apr; 14(4):265-74. PubMed ID: 8924194
    [Abstract] [Full Text] [Related]

  • 51. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR, Duncan GE, Napier TC, Bondy SC, Iorio LC, Mueller RA.
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [Abstract] [Full Text] [Related]

  • 52. Nigral D1 and striatal D2 receptors mediate the behavioral effects of dopamine agonists.
    LaHoste GJ, Marshall JF.
    Behav Brain Res; 1990 May 28; 38(3):233-42. PubMed ID: 1973041
    [Abstract] [Full Text] [Related]

  • 53. Agonist efficacy and the behavioral effects of dopamine D1 receptor ligands: drug interaction studies in squirrel monkeys.
    Bergman J, Spealman RD, Madras BK, Rosenzweig-Lipson S.
    J Pharmacol Exp Ther; 1996 Mar 28; 276(3):942-50. PubMed ID: 8786574
    [Abstract] [Full Text] [Related]

  • 54. The D2 agonist quinpirole potentiates the discriminative stimulus effects of the D1 agonist SKF 38393.
    Williams JE, Woolverton WL.
    Pharmacol Biochem Behav; 1990 Oct 28; 37(2):289-93. PubMed ID: 1981936
    [Abstract] [Full Text] [Related]

  • 55. SKF 83959 is an antagonist of dopamine D1-like receptors in the prefrontal cortex and nucleus accumbens: a key to its antiparkinsonian effect in animals?
    Cools AR, Lubbers L, van Oosten RV, Andringa G.
    Neuropharmacology; 2002 Feb 28; 42(2):237-45. PubMed ID: 11804620
    [Abstract] [Full Text] [Related]

  • 56. Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs.
    Tidey JW, Bergman J.
    J Pharmacol Exp Ther; 1998 Jun 28; 285(3):1163-74. PubMed ID: 9618419
    [Abstract] [Full Text] [Related]

  • 57. [The role of D1 and D2 dopamine receptors of the rat nucleus accumbens in immunostimulation].
    Devoĭno LV, Al'perina EL, Gevorgian MM, Cheĭdo MA.
    Ross Fiziol Zh Im I M Sechenova; 2005 Nov 28; 91(11):1281-7. PubMed ID: 16408636
    [Abstract] [Full Text] [Related]

  • 58. D1 or D2 antagonism in nucleus accumbens core or dorsomedial shell suppresses lever pressing for food but leads to compensatory increases in chow consumption.
    Nowend KL, Arizzi M, Carlson BB, Salamone JD.
    Pharmacol Biochem Behav; 2001 Nov 28; 69(3-4):373-82. PubMed ID: 11509194
    [Abstract] [Full Text] [Related]

  • 59. Activation of both dopamine D1 and D2 receptors necessary for amelioration of conditioned fear stress.
    Kamei H, Kameyama T, Nabeshima T.
    Eur J Pharmacol; 1995 Feb 06; 273(3):229-33. PubMed ID: 7737329
    [Abstract] [Full Text] [Related]

  • 60. Prior D1 dopamine receptor stimulation is required to prime D2-mediated striatal Fos expression in 6-hydroxydopamine-lesioned rats.
    Pollack AE, Yates TM.
    Neuroscience; 1999 Feb 06; 94(2):505-14. PubMed ID: 10579212
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 22.